Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $5.9352W HIGH $14.71
Volume
2.78 M
Value Traded
13.87 M
Short % Float
4.9%
Days to Cover
1.6
+2.77%Week
-1.74%1 Month
+43.06%3 Month
+99.54%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
2.84 B
EPS (TTM)
1.26
P/E Ratio
10.32
Ent. Value
4.05 B
Total Shares
218.22 M
Float Shares
115.68 M
Insiders
47.01%
Institutions
43.64%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
AVAH Catalyst Timeline
Dated clinical, regulatory and corporate events for Aveanna Healthcare Holdings Inc. Common Stock
Past FDA Catalysts and PDUFA Decisions
How AVAH actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Aveanna Healthcare Holdings Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AVAH program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ERICA G SCHWARTZDirector | Sell | 46,071 | $14.00 | 09/09/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in AVAH
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PARKMAN HEALTHCARE PARTNERS LLC | 0.6 % | 6.12 M | 714.45 K |
AVAH Institutional Ownership Trends
AVAH Short Interest
Shares sold short, counted twice a month.
4.9%
Short % of Float
of tradable shares sold short
5.7M
Shares Sold Short
+3.0% vs prior count
1.6 Low
Days to Cover
trading days of normal volume to buy every short share back
3.5M
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How AVAH ranks across every disease it competes in
Competitive Position is a premium feature
See how AVAH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialAVAH News
-AVAH
Oct 22, 2026▲ +1.9%today
Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. will announce its third quarter results on November 12, 2026, before the market opens. A conference call will follow at 10:00 a.m. ET, accessible via phone and webcast. Investors can expect insights into the company's performance and services during this call.
Read more →-AVAH
Aug 27, 2026Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit
Aveanna Healthcare Holdings Inc. will participate in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026. The management team will host a fireside chat and conduct one-on-one investor meetings. Interested parties can access a live webcast of the presentation through the company's Investor Relations website.
Read more →-AVAH
Aug 25, 2026Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Aveanna Healthcare Holdings Inc. will participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. The management team is scheduled to present at 4:10pm CST and will also conduct one-on-one investor meetings. Interested parties can access a live webcast of the presentation through the company's Investor Relations website.
Read more →-AVAH
Aug 21, 2026Aveanna Announces Pricing of Secondary Offering of Common Stock
Aveanna Healthcare Holdings Inc. has announced the pricing of a secondary offering of 15 million shares at $11.75 each, with proceeds going to selling stockholders. The offering is expected to settle on August 24, 2026, and RBC Capital Markets is the sole book-running manager. The company will not receive any proceeds from this sale.
Read more →-AVAH
Aug 20, 2026Aveanna Announces Launch of Secondary Offering of Common Stock
Aveanna Healthcare Holdings Inc. has announced a secondary offering of 15 million shares of common stock by certain selling stockholders, including affiliates of J.H. Whitney Equity Partners. The company will not receive any proceeds from this offering, and RBC Capital Markets is the sole book-running manager. The offering includes an option for underwriters to purchase additional shares.
Read more →-AVAH
Aug 13, 2026▲ +24.8%on this news· ran to +40% by day 3
Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
Aveanna Healthcare Holdings reported strong financial results for the second quarter of 2026, with revenue reaching $670.5 million, a 13.7% increase compared to the previous year. Net income also saw significant growth, rising to $40.3 million. The company has raised its full-year revenue and adjusted EBITDA guidance, reflecting confidence in its operational strategies and market position.
Read more →-AVAH
Jul 23, 2026Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its second quarter earnings, set for August 13, 2026. Following the earnings release, a conference call will be held at 10:00 a.m. ET. Investors can access the call via phone or webcast, with a replay available shortly after the event.
Read more →-AVAH
Jun 2, 2026Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance
Aveanna Healthcare Holdings has completed the acquisition of Family First Homecare for $175.5 million, enhancing its pediatric home care services across seven states. The acquisition is expected to contribute an additional $70 million in revenue and $10 million in Adjusted EBITDA for the fiscal year 2026. Aveanna has updated its guidance to reflect this positive impact, indicating strong growth potential and strategic expansion.
Read more →-AVAH
May 28, 2026Aveanna Healthcare Announces Successful Debt Repricing
Aveanna Healthcare announced the successful repricing of its first lien and revolving credit facilities, resulting in a 50 basis point reduction in interest rates. An additional reduction of 25 basis points is possible with a favorable credit rating. The CFO expressed confidence in the company's operational excellence and strategic growth plans.
Read more →-AVAH
May 15, 2026Investor Presentation May 2026 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information purpo
Aveanna Healthcare Holdings Inc. provided an investor presentation outlining disclaimers and forward-looking statements. The presentation emphasizes that the information is for informational purposes only and does not constitute an offer or recommendation to purchase securities. It also stresses that certain statements are forward-looking and dependent on various assumptions, which may not hold true. Risks associated with these statements include challenges in executing growth strategies and uncertainties in future performance.
Read more →-AVAH
May 14, 2026▲ +9.9%on this newsshared move
Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance
Aveanna Healthcare Holdings reported strong financial results for Q1 2026, with revenue reaching $647.9 million, a 15.9% increase year-over-year. Net income surged to $41.7 million compared to $5.2 million in the prior year. The company also raised its full-year revenue and adjusted EBITDA guidance, reflecting positive operational trends and growth potential.
Read more →-AVAH
May 12, 2026Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
Aveanna Healthcare Holdings Inc. will participate in the William Blair 46th Annual Growth Stock Conference on June 2, 2026. The management team is scheduled to present at 2:40 PM CST and will conduct one-on-one investor meetings. Interested parties can access a live webcast of the presentation through the company's Investor Relations website.
Read more →-AVAH
Apr 28, 2026Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference
Aveanna Healthcare Holdings Inc. will participate in the Barclays 30th Annual Leveraged Finance Conference in Austin, TX on May 19, 2026. The management team will host one-on-one investor meetings, showcasing the company's commitment to investor engagement. Aveanna provides a wide range of healthcare services across 38 states.
Read more →-AVAH
Apr 23, 2026Aveanna Announces First Quarter 2026 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its first quarter 2026 earnings, scheduled for May 14, 2026. A conference call will follow at 10:00 a.m. ET, allowing investors to engage directly with the company. The call will be accessible via phone and webcast, with a replay available shortly after.
Read more →-AVAH
Mar 19, 2026▼ -8.2%on this news
Investor Presentation March 2026 Disclaimers and Forward-Looking Statements This investor presentation (this presentation“) and any oral statements made in connection with this presentation are for information pur
The investor presentation from Aveanna Healthcare Holdings Inc. outlines various disclaimers and forward-looking statements regarding the company's financial position and strategies. It emphasizes that the information is for informational purposes only and should not be considered an offer to buy securities. Significant risks and uncertainties are acknowledged that may affect the company's future performance. The presentation also highlights that past performance is not indicative of future results, underscoring the variability in business forecasts.
Read more →-AVAH
Mar 19, 2026▼ -8.2%on this news
AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
Aveanna Healthcare Holdings reported strong financial results for the fourth quarter and full year 2025, with significant growth in revenue and net income. Fourth quarter revenue reached $662.5 million, marking a 27.4% increase year-over-year, while net income soared to $178.8 million compared to $29.2 million previously. The company maintained its revenue and adjusted EBITDA guidance for 2026 amid its ongoing strategic transformation. Additionally, Aveanna announced an agreement to acquire Family First Homecare, which will expand its service offerings in pediatric home care.
Read more →-AVAH
Mar 12, 2026AVEANNA HEALTHCARE HOLDINGS ANNOUNCES AGREEMENT TO ACQUIRE FAMILY FIRST HOMECARE
Aveanna Healthcare Holdings has announced an agreement to acquire Family First Homecare, a pediatric home care provider with 27 locations across several states. This acquisition aims to enhance Aveanna's specialized care model and expand its geographic footprint. Both companies' leadership expressed confidence in the cultural fit and shared mission of providing high-quality care. The transaction is expected to close in the second fiscal quarter of 2026, though it faces customary closing conditions and potential operational risks.
Read more →-AVAH
Feb 26, 2026Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. has announced the release date for its fourth quarter and full year 2025 earnings, set for March 19, 2026. The announcement includes details about a conference call scheduled for the same day at 10:00 a.m. Eastern Time. Investors can access the call via phone or webcast, with a replay available afterward.
Read more →-AVAH
Feb 20, 2026AVEANNA HEALTHCARE, LLC Name: Title: EXECUTIVE Name
Aveanna Healthcare has entered into a new employment agreement with Jeffrey Shaner, continuing his tenure as CEO. The agreement, effective from February 17, 2026, replaces a prior contract from December 2016. The terms include a base salary of $750,000, eligibility for annual bonuses, and equity compensation, ensuring continuity in leadership for the company.
Read more →-AVAH
Feb 11, 2026Aveanna’s Heartways Program Receives CHAP Disease Program Certification
Aveanna Healthcare's Heartways program has achieved CHAP Disease Program Certification for Heart Failure, reflecting its commitment to high-quality care standards. This certification indicates that Aveanna meets rigorous evaluation criteria, enhancing patient outcomes through comprehensive education and symptom management. The program aims to reduce hospitalizations and improve quality of life for patients with heart disease.
Read more →About Aveanna Healthcare Holdings Inc. Common Stock
Headquarters400 INTERSTATE NORTH PARKWAY, ATLANTA, GA, 30339
BIOPHARMAWATCH ELITE PLUS
Trade the next AVAH catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime